Bevacizumab vs Dacarbazine in Metastatic Melanoma
Condition(s):Metastatic Malignant Melanoma; Unresectable Malignant MelanomaLast Updated:February 24, 2017Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Malignant Melanoma; Unresectable Malignant MelanomaLast Updated:February 24, 2017Terminated
Condition(s):Myocardial Fibrosis; Muscular DystrophiesLast Updated:May 4, 2015Completed
Condition(s):Orthostatic Hypotension; Spinal Cord InjuriesLast Updated:June 23, 2014Completed
Condition(s):Heart FailureLast Updated:June 18, 2023Recruiting
Condition(s):HypertensionLast Updated:August 27, 2015Completed
Condition(s):HypertensionLast Updated:July 18, 2018Unknown status
Condition(s):Uric Acid NephropathyLast Updated:November 28, 2022Recruiting
Condition(s):Pre-diabetes; Pre-hypertensionLast Updated:June 2, 2011Unknown status
Condition(s):HypertensionLast Updated:February 19, 2014Completed
Condition(s):Heart Defects, Congenital; Heart Septal Defects, Ventricular; Heart Failure, CongestiveLast Updated:March 13, 2014Terminated
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.